Healthcare provider profile · identity verified

Matthew Joseph

Internal Medicine · SEWICKLEY, PA · NPI 1124346978

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	615	171
Amlodipine Besylate	Amlodipine Besylate	498	147
Levothyroxine Sodium	Levothyroxine Sodium	363	91
Omeprazole	Omeprazole	295	80
Rosuvastatin Calcium	Rosuvastatin Calcium	265	89
Losartan Potassium	Losartan Potassium	255	70
Lisinopril	Lisinopril	246	75
Pantoprazole Sodium	Pantoprazole Sodium	204	63
Metformin Hcl	Metformin Hcl	196	55
Gabapentin	Gabapentin	191	55
Simvastatin	Simvastatin	187	55
Fluticasone Propionate	Fluticasone Propionate	176	64
Hydrochlorothiazide	Hydrochlorothiazide	174	50
Tamsulosin Hcl	Tamsulosin Hcl	166	49
Metoprolol Tartrate	Metoprolol Tartrate	154	42
Metoprolol Succinate	Metoprolol Succinate	144	47
Pravastatin Sodium	Pravastatin Sodium	142	49
Eliquis	Apixaban	137	35
Atenolol	Atenolol	123	30
Synthroid	Levothyroxine Sodium	116	31
Sertraline Hcl	Sertraline Hcl	110	30
Famotidine	Famotidine	105	35
Furosemide	Furosemide	96	38
Fluoxetine Hcl	Fluoxetine Hcl	88	26
Montelukast Sodium	Montelukast Sodium	87	21
Escitalopram Oxalate	Escitalopram Oxalate	81	21
Albuterol Sulfate Hfa	Albuterol Sulfate	73	42
Duloxetine Hcl	Duloxetine Hcl	73	20
Oxycodone Hcl	Oxycodone Hcl	73	17
Enalapril Maleate	Enalapril Maleate	68	19
Clonazepam	Clonazepam	65	19
Trazodone Hcl	Trazodone Hcl	65	20
Potassium Chloride	Potassium Chloride	64	19
Allopurinol	Allopurinol	60	22
Finasteride	Finasteride	60	15
Carvedilol	Carvedilol	57	17
Lorazepam	Lorazepam	57	23
Xarelto	Rivaroxaban	55	11
Alprazolam	Alprazolam	52	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	12
Prednisone	Prednisone	47	25
Clopidogrel	Clopidogrel Bisulfate	46	16
Doxycycline Hyclate	Doxycycline Hyclate	45	35
Meloxicam	Meloxicam	44	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	15
Amoxicillin	Amoxicillin	42	33
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	suppressed
Bupropion Hcl Sr	Bupropion Hcl	41	12
Methylprednisolone	Methylprednisolone	41	38
Ezetimibe	Ezetimibe	39	12
Jardiance	Empagliflozin	39	16
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	32
Ipratropium Bromide	Ipratropium Bromide	37	suppressed
Valsartan	Valsartan	37	11
Tramadol Hcl	Tramadol Hcl	36	12
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	20
Azelastine Hcl	Azelastine Hcl	33	12
Metformin Hcl Er	Metformin Hcl	33	11
Methocarbamol	Methocarbamol	31	12
Ozempic	Semaglutide	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Glipizide	Glipizide	25	suppressed
Azithromycin	Azithromycin	24	17
Irbesartan	Irbesartan	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	12
Meclizine Hcl	Meclizine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	19
Propranolol Hcl	Propranolol Hcl	19	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nystatin	Nystatin	17	14
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	15
Spironolactone	Spironolactone	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Mupirocin	Mupirocin	15	12
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Cephalexin	Cephalexin	14	13
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Terazosin Hcl	Terazosin Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error